Castle Biosciences Corp - Bathi resik saben saham (EPS TTM) CSTL

Castle Biosciences generates revenue through the implementation of advanced genetic tests for assessing recurrences of skin neoplasms. The large-scale adoption of these studies in clinics ensures sustainable growth for the company. Strong pricing power is supported by the critical importance of diagnostics for melanoma therapy. Analyzing the annual EPS TTM chart on GURU.Markets, we find that the value is fixed at -81.70.

Castle Biosciences Corp (CSTL) - Bathi resik saben saham sajrone 12 wulan pungkasan saka 11.02.2024 nganti 15.11.2026

castlebiosciences.com - rincian analitis lan metrik utama (CSTL)

- rega saham lan konsensus proyeksi valuasi:

Kurs saham Castle Biosciences, Inc.|CSTL - Prakiraan konsensus analis

- rincian nilai pasar emiten:

Kapitalisasi pasar Castle Bio|CSTL - Nilai Total Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Siji Saham Castle Biosciences|CSTL - Aset Bersih Perusahaan|Koefisien Nilai Pasar marang Nilai Buku castlebiosciences.com|CSTL - Aset Agregat Perusahaan

- data utang lan likuiditas:

Koefisien Total Utang marang Modal Castle Biosciences|CSTL - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal castlebiosciences.com|CSTL - Utang perusahaan|Utang-utang marang aset resik Castle Biosciences Corp|CSTL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Castle Biosciences|Rasio cepet castlebiosciences.com

- indikator bathi lan kelipatan valuasi:

CSTL - Bathi resik perusahaan|Prakiraan bathi perusahaan Castle Biosciences|CSTL - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep Castle Bio|CSTL - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Castle Biosciences Corp|CSTL - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Castle Biosciences|CSTL - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan castlebiosciences.com|CSTL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Castle Biosciences

- informasi babagan volume dodolan lan pendapatan:

CSTL - Pendapatan lan volume dodolan|Dodolan mangsa ngarep perusahaan Castle Biosciences Inc|CSTL - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Castle Bio|CSTL - Wutah dodolan YoY sajrone rolas wulan kepungkur

Analisis wiwitan perusahaan:CSTL (Castle Biosciences, Inc.)

Cost optimization through cloud data analysis and logistics outsourcing allows Castle Biosciences (CSTL) to scale operational efficiency. The trend of this profit, calculated as the percentage change in rolling annual EPS, determines the real cost of capital under tight Fed policy, making the current TTM EPS annual growth value a key indicator for identifying undervalued assets.

Analisis pesaing Castle Biosciences